Approvals/TGA/FLEBOGAMMA 5% DIF Human normal immunoglobulin 2.5g/50mL intravenous use injection vial

Approved

STANDARD

FLEBOGAMMA 5% DIF Human normal immunoglobulin 2.5g/50mL intravenous use injection vial

Grifols Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 58d94966a9f2f149
Product Name: FLEBOGAMMA 5% DIF Human normal immunoglobulin 2.5g/50mL intravenous use injection vial
Artg Id: 143800
Artg Name: FLEBOGAMMA 5% DIF normal immunoglobulin (Human) 2.5g/50mL intravenous use injection vial
Sponsor: Grifols Australia Pty Ltd
Company Detail Path: /organization/grifols-australia-pty-ltd
Artg Date: 2008-12-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01069-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01068-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

58d94966a9f2f149

Type

Standard